Clinical Trial Update: Clemizole HCl for Subjects With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update for Clemizole hydrochloride in hepatocellular carcinoma, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Clemizole HCl (clemizole hydrochloride)

Snippet

Sponsor: Eiger Group International, Inc. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN